OMIA:001317-176043 : Mucopolysaccharidosis II in Nestor meridionalis (Kaka)

In other species: dog

Categories: Lysosomal storage disease

Possibly relevant human trait(s) and/or gene(s) (MIM number): 309900 (trait)

Links to MONDO diseases: No links.

Mendelian trait/disorder: unknown

Considered a defect: yes

Genetic engineering: Unknown
Have human generated variants been created, e.g. through genetic engineering and gene editing

Clinical features: Jolly et al. (2021): "a free-living kaka (Nestor meridionalis) ... exhibited weakness, incoordination and seizures."

Pathology: Jolly et al. (2021): "Histopathology showed typical colloid-like cytoplasmic inclusions in Purkinje cells and many other neurons throughout the brain. Electron microscopy revealed that storage bodies contained a variety of linear, curved, or circular membranous profiles and electron-dense bodies. ... Tandem mass spectrometry revealed increased levels of heparan sulfate-derived disaccharides in the brain and liver compared with tissues from controls. Enzymatic assays documented low levels of iduronate-2-sulfatase activity, which causes a lysosomal storage disorder called mucopolysaccharidosis type II or Hunter syndrome."

Cite this entry

Nicholas, F. W., Tammen, I., & Sydney Informatics Hub. (2021). OMIA:001317-176043: Online Mendelian Inheritance in Animals (OMIA) [dataset]. https://omia.org/. https://doi.org/10.25910/2AMR-PV70

Reference

2021 Jolly, R.D., Hunter, S.A., Alley, M.R., King, B.M., Lau, A.A., Trim, P.J., Snel, M.F., Hemsley, K.M. :
Mucopolysaccharidosis II (MPS II) in a free-living kaka (Nestor meridionalis) in New Zealand. J Wildl Dis , 2021. Pubmed reference: 34424960. DOI: 10.7589/JWD-D-20-00173.

Edit History


  • Created by Imke Tammen2 on 25 Aug 2021